.

Motley Crue Stadium Tour With Def Leppard Topped $170 Million (2022 In Review)


Bruce Henne | December 29, 2022

Motley Crue Photo by antiMusic's Rob Grabowski
Photo by antiMusic's Rob Grabowski

(hennemusic) Motley Crue Stadium Tour With Def Leppard Tops $170 Million was a top 22 story from September 2022: Motley Crue's North American stadium tour with Def Leppard and Poison earned more than $170 million, according to a new report by Billboard.

The 36-city series - with guests Poison and Joan Jett & The Blackhearts - sold 1.3 million tickets to deliver $173.5 million in revenue at the box office, which Billboard says makes it the biggest tour of either Motley Crue's or Def Leppard's career, dating back to when the Billboard Boxscore began collecting data in the late 1980s.

"The Stadium Tour" averaged 37,520 tickets each night, drawing more than three times the audience that each band previously reached on their own.

Motley Crue reunited for the series following a "farewell tour" that ended in 2015, while Def Leppard were on the road in support of their latest album, "Diamond Star Halos"; both bands have hinted that the tour will continue in 2023.

Read more here.

Related Stories
Motley Crue Add Fourth Show For 2024

Motley Crue's Tommy Lee Updates On Fans On Surgery Recovery

Mick Mars Streams Debut Album The Other Side Of Mars

Slayer, Iron Maiden, Motley Crue, Pantera and Slipknot Lead Aftershock Lineup

Mick Mars Addresses Working With Motley Crue Again


News > Motley Crue


Share this article: Share on Facebook Share on Twitter Share on Reddit email this article